-
APLS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Apellis Pharmaceuticals (APLS)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 412.61 mm | 412.61 mm | 412.61 mm | 412.61 mm | 412.61 mm | 412.61 mm |
Cash burn (monthly) | (no burn) | (no burn) | 12.02 mm | 16.39 mm | (no burn) | 7.32 mm |
Cash used (since last report) | n/a | n/a | 27.60 mm | 37.63 mm | n/a | 16.81 mm |
Cash remaining | n/a | n/a | 385.02 mm | 374.98 mm | n/a | 395.80 mm |
Runway (months of cash) | n/a | n/a | 32.0 | 22.9 | n/a | 54.1 |
13F holders | Current |
---|---|
Total holders | 261 |
Opened positions | 58 |
Closed positions | 64 |
Increased positions | 97 |
Reduced positions | 70 |
13F shares | Current |
---|---|
Total value | 4.00 tn |
Total shares | 139.47 mm |
Total puts | 839.50 k |
Total calls | 2.62 mm |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Morningside Venture Investments | 12.81 mm | $0.00 |
Avoro Capital Advisors | 12.22 mm | $390.01 bn |
EcoR1 Capital | 11.89 mm | $379.44 bn |
Wellington Management | 11.80 mm | $376.57 bn |
Vanguard | 10.05 mm | $320.57 bn |
MS Morgan Stanley | 9.63 mm | $307.20 bn |
BlackRock | 6.48 mm | $206.71 bn |
STT State Street | 4.53 mm | $144.40 bn |
Deep Track Capital | 4.27 mm | $136.41 bn |
Octagon Capital Advisors | 3.01 mm | $95.95 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Mar 25 | David O. Watson | Common Stock | Sell | Dispose S | No | No | 25.1013 | 5,569 | 139.79 k | 138,730 |
4 Mar 25 | David O. Watson | Common Stock | Gift | Acquire G | Yes | No | 0 | 6,667 | 0.00 | 10,000 |
4 Mar 25 | David O. Watson | Common Stock | Gift | Dispose G | Yes | No | 0 | 6,667 | 0.00 | 0 |
11 Feb 25 | Mark Jeffrey DeLong | Common Stock | Sell | Dispose S | No | No | 28.5388 | 363 | 10.36 k | 83,945 |
29 Jan 25 | Mark Jeffrey DeLong | Common Stock | Sell | Dispose S | No | No | 29.5236 | 365 | 10.78 k | 84,308 |
29 Jan 25 | Francois Cedric | Common Stock | Sell | Dispose S | No | No | 29.5236 | 2,824 | 83.37 k | 415,695 |
29 Jan 25 | Deschatelets Pascal | Common Stock | Sell | Dispose S | No | No | 29.5236 | 826 | 24.39 k | 1,147,716 |